Saturday, 3 October 2026European Markets

ZENOBE GRAMME CERT Stock 12.64% Up Today

Loading stream...

(VIANEWS) - The Market ended the session with ZENOBE GRAMME CERT (ZEN.BR) rising 12.64% to €196.00 on Monday while BEL 20 rose 0.1% to €3,707.77.

ZENOBE GRAMME CERT's last close was €196.00, 12.46% below its 52-week high of €223.90.

About ZENOBE GRAMME CERT

Immo-Zenobe Gramme SA engages in the issuance of real estate certificates in Belgium. Immo-Zenobe Gramme SA is based in Molenbeek-Saint-Jean, Belgium. Immo-Zenobe Gramme SA operates as a subsidiary of KBC Bank NV.

Earnings Per Share

As for profitability, ZENOBE GRAMME CERT has a trailing twelve months EPS of €0.17.

PE Ratio

ZENOBE GRAMME CERT has a trailing twelve months price to earnings ratio of 1152.94. Meaning, the purchaser of the share is investing €1152.94 for every euro of annual earnings.

Volatility

ZENOBE GRAMME CERT's last week, last month's, and last quarter's current intraday variation average was 5.46%, 2.23%, and 5.40%.

ZENOBE GRAMME CERT's highest amplitude of average volatility was 7.18% (last week), 3.54% (last month), and 5.40% (last quarter).

Volume

Today's last reported volume for ZENOBE GRAMME CERT is 27 which is 18.18% below its average volume of 33.

More news about ZENOBE GRAMME CERT (ZEN.BR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com
ZENOBE GRAMME CERT Stock 12.64% Up Today | ViaNews EU